A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

Clinical trial NCT01711346 · COMPLETED

Trial details

NCT number: NCT01711346
Sponsor: Cerus Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Focus: Assess Post Infusion Viability of S303 RBCs

Start date: 2012-10-01
Primary completion: 2014-07-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.